Publications
Outcomes of Patients with Primary Mediastinal B-Cell Lymphoma Treated with Dose Adjusted R-EPOCH Regimen: A Single Centre Experienc
Jain H, Kapoor A, Sengar M, Chanana R, Menon H, Sridhar E, Laskar S, Agarwal A, Shastri J, Khanna N, Rangarajan V, Bagal B, Thorat J, Shet T, Gujral S. Primary Mediastinal B cell lymphoma (PMBCL) is a biologically and clinically distinct subset of diffuse large B cell lymphoma. We analysed the outcomes of our cohort of PMBCL patients treated with Dose adjusted (DA)-R-EPOCH regimen.
